The ferroptosis inducer erastin enhances sensitivity of acute myeloid leukemia cells to chemotherapeutic agents
Impact in
Classified as
- Journal
- Molecular & Cellular Oncology
In The Last Decade
doi.org/10.1080/23723556.2015.1054549 →Countries where authors are citing The ferroptosis inducer erastin enhances sensitivity of acute myeloid leukemia cells to chemotherapeutic agents
This map shows the geographic impact of The ferroptosis inducer erastin enhances sensitivity of acute myeloid leukemia cells to chemotherapeutic agents. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by The ferroptosis inducer erastin enhances sensitivity of acute myeloid leukemia cells to chemotherapeutic agents with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites The ferroptosis inducer erastin enhances sensitivity of acute myeloid leukemia cells to chemotherapeutic agents more than expected).
Fields of papers citing The ferroptosis inducer erastin enhances sensitivity of acute myeloid leukemia cells to chemotherapeutic agents
This network shows the impact of The ferroptosis inducer erastin enhances sensitivity of acute myeloid leukemia cells to chemotherapeutic agents. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the The ferroptosis inducer erastin enhances sensitivity of acute myeloid leukemia cells to chemotherapeutic agents.
About The ferroptosis inducer erastin enhances sensitivity of acute myeloid leukemia cells to chemotherapeutic agents
This paper, published in 2015, received 396 indexed citations . Written by Yu Yan, Yangchun Xie, Lizhi Cao, Liangchun Yang, Minghua Yang, Michael T. Lotze, Herbert J. Zeh, Rui Kang and Daolin Tang covering the research area of Oncology, Pulmonary and Respiratory Medicine and Cancer Research. It is primarily cited by scholars working on Pulmonary and Respiratory Medicine (314 citations), Molecular Biology (243 citations), Cancer Research (211 citations), Oncology (60 citations) and Hematology (30 citations). Published in Molecular & Cellular Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
This paper is also available at doi.org/10.1080/23723556.2015.1054549.